moxisylyte has been researched along with Polycystic Ovarian Syndrome in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paradisi, R | 1 |
| Venturoli, S | 1 |
| Capelli, M | 1 |
| Spada, M | 1 |
| Giambiasi, ME | 1 |
| Magrini, O | 1 |
| Porcu, E | 1 |
| Fabbri, R | 1 |
| Flamigni, C | 1 |
1 other study available for moxisylyte and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Effects of alpha 1-adrenergic blockade on pulsatile luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in polycystic ovary syndrome.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Female; Follicle Stimulating Hormone; Humans; Lutei | 1987 |